Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Manolete Partners Plc LSE:MANO London Ordinary Share GB00BYWQCY12 ORD 0.4P
  Price Change % Change Share Price Shares Traded Last Trade
  -5.00 -0.91% 545.00 20,274 12:48:15
Bid Price Offer Price High Price Low Price Open Price
540.00 550.00 550.00 540.00 550.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 13.77 5.94 32.00 17.0 237
Last Trade Time Trade Type Trade Size Trade Price Currency
12:42:35 O 2,500 550.00 GBX

Manolete Partners (MANO) Latest News

More Manolete Partners News
Manolete Partners Takeover Rumours

Manolete Partners (MANO) Discussions and Chat

Manolete Partners Forums and Chat

Date Time Title Posts
20/5/202015:15::: MANOLETE PARTNERS :::293
01/5/201914:14Manolete Partners at the UK Investor Show-

Add a New Thread

Manolete Partners (MANO) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:42:36550.002,50013,750.00O
11:07:52550.001,0005,500.00O
10:56:17550.004,70725,888.50O
09:28:22535.202,17111,619.19O
09:21:19549.6090494.64O
View all Manolete Partners trades in real-time

Manolete Partners (MANO) Top Chat Posts

DateSubject
02/6/2020
09:20
Manolete Partners Daily Update: Manolete Partners Plc is listed in the General Financial sector of the London Stock Exchange with ticker MANO. The last closing price for Manolete Partners was 550p.
Manolete Partners Plc has a 4 week average price of 480p and a 12 week average price of 235p.
The 1 year high share price is 600p while the 1 year low share price is currently 235p.
There are currently 43,571,425 shares in issue and the average daily traded volume is 17,895 shares. The market capitalisation of Manolete Partners Plc is £237,464,266.25.
09/4/2020
12:29
xpertgreeny: New report on insolvency litigation market shows growth to £1.5Bn a year and big shift to funders like MANO. Impact of 2015 and 2016 legal changes. MANO share of funders slice up from 52% to 67%. https://www.lawgazette.co.uk/news/insolvency-litigation-market-grows-to-15bn/5103831.article#.Xo7_rR6HJRM.twitter
02/1/2020
08:54
jonwig: The current NAV - isn't it about 71p? Whilst I wouldn't use that as a measure to compare the share price with, its rate of growth might be. The trouble is that the number is distorted by the recent IPO funds and big expansion in investments, so it will be a while before we can get anything much from that. Actually, the rate of NAV growth ought to be much the same as the rate of earnings growth (divis are negligible), so I'm going to stick with the bottom line and with eps. Maybe the most interesting account is cashflow: cash fell from £9.7m to £3.1m between March and September through investing the IPO funds. I'd expect the cash pile to get topped-up by March.
21/11/2019
08:26
jonwig: HY results: https://www.investegate.co.uk/manolete-partners--mano-/rns/half-year-results/201911210700151352U/ Share price reaction will be based on what expectations were. But also there's the issue of fair value movements which may hold the shares back.
08/8/2019
13:15
xpertgreeny: Peel Hunt on Bloomberg: Manolete Partners# (Add from Hold, TP 450p) - Financially healthy, recommendation upgrade Manolete Partners is in excellent financial health, with net cash (nil borowings) of probably £7.5m today, and has a completely different profile to other litigation funders. Its returns are much higher than others in the industry, it has a strong cash collection record, case duration is typically short – currently less than one year – it is in much greater control of its cases, it has a wide network of partners that bring repeat business, and it has more visibility on its growth than others as regional teams are built out. Following recent share price weakness we upgrade to Add from Hold, TP 450p. Arden, also today, reiterate Buy. TP: 590p
02/5/2019
10:42
gaiusgracchus: On March 20 I said in this thread: "CEO presented at the Shares event tonight. I'm not [going] to provide any deep analysis...but I think the shares have plenty of room to run over the next 3 years." The share price was 397p then...I'm starting to wonder how much of that room to run for the share price has already taken place?
02/5/2019
05:28
jonwig: That would be short-sighted. As you'll know, the Cannacord broker note was a false flag. The share price here is also being helped by the presentations they're making. BUR now seriously undervalued. This one, probably not.
07/4/2019
13:34
williamcooper104: Sold some more Mano - won’t cry too much if stock falls by 30 percent from here (which of course it could - and would still be on c35x - and that’s probably the right price for the stock IMO at this time) Mano are quite different from Bur Hybrid debt collector and litigation funder with a very specific niche - most of their claims are preferences/illegal dividends - eg shareholders taking money out before a bankruptcy. There’s no currency risk for GBP investors The regulatory risks are different from Bur So I’m happy to be a long term Mano holder as I think it’s a good compliment with Bur My bear point on the company (other than current share price) is that their capital efficiency in buying claims for little/no money and making quick returns begs the question why IPs sell claims. True administrators often have little funding to litigate and they all are under pressure to wrap up insolvencies and banks/IPs often give away huge value tomorrow for cash today. Mitigating that concern is of course the track record of buying many claims Into LIT too - not as confident - and perhaps in there for the wrong reasons eg because have had outsized returns in the sector Can afford for my holdings in Bur/LIT/Mano to go to zero and still have made a very decent return - but that could cloud my judgment
27/3/2019
14:35
jonwig: stoxx - I share your perplexity; I did expect this to be a decent investment, but the share price looks pretty irrational at these levels. It's worth watching the latest sharesmag video presentation where the CEO actually suggests what the PER should be (was it 55x?), which is out of order ... maybe he's getting carried away? On the other hand, you can also see the potential rate of growth and its strong ethical position ("let's shaft crooked directors"). Another thing, Burford actually had a shareholding in Manolete a few years ago but sold out. Maybe they aren't bothered, as the size difference is so extreme. EDIT: IamM ... sorry, missed your response whilst writing mine. Agree with you!
26/3/2019
06:33
jonwig: Dave - am I still in BUR? Sure, but I'm pretty indifferent to the ups and downs of the share price which is the way most of the discussion there is going. The MANO CEO has done lots of presentations, generating interest. Maybe there'll be a pullback at some point, could be after FY results around late May/early June. Personally I wouldn't add at this level.
19/2/2019
07:12
jonwig: Yes, very impressive. I guess this information had escaped into the public domain, given the share price moves recently. Or maybe another boost to come, we'll see at 8;00. Link to statement: https://www.investegate.co.uk/manolete-partners--mano-/rns/trading-update/201902190700114167Q/
Manolete Partners share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
MANO
Manolete P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 12:32:56